Kestra Advisory Services’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-336
Closed -$17K 2229
2022
Q1
$17K Hold
336
﹤0.01% 1984
2021
Q4
$15K Hold
336
﹤0.01% 1996
2021
Q3
$22K Hold
336
﹤0.01% 2105
2021
Q2
$34K Hold
336
﹤0.01% 1987
2021
Q1
$43K Hold
336
﹤0.01% 1833
2020
Q4
$37K Hold
336
﹤0.01% 1825
2020
Q3
$40K Buy
+336
New +$58.1K ﹤0.01% 1391

Other funds holding RMTI

Kestra Advisory Services's RMTI Position: Q2 2022 in Review

Kestra Advisory Services sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 336 shares — an estimated $17K sold.

Kestra Advisory Services first reported a position in RMTI in Q3 2020 and held it in 7 quarters. The position peaked at $43K in Q1 2021. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.

  • Kestra Advisory Services reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
  • Kestra Advisory Services sold 336 Rockwell Medical shares in Q2 2022, an estimated $17K.
  • Kestra Advisory Services first reported a position in Rockwell Medical in Q3 2020 and held it in 7 quarters.
  • Kestra Advisory Services's Rockwell Medical position peaked at $43K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.

Based on Kestra Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.